| Coinhibitory pathways in immunotherapy for cancer SH Baumeister, GJ Freeman, G Dranoff, AH Sharpe Annual review of immunology 34 (1), 539-573, 2016 | 1007 | 2016 |
| Phase I trial of autologous CAR T cells targeting NKG2D ligands in patients with AML/MDS and multiple myeloma SH Baumeister, J Murad, L Werner, H Daley, H Trebeden-Negre, ... Cancer immunology research 7 (1), 100-112, 2019 | 303 | 2019 |
| Mechanisms of acute toxicity in NKG2D chimeric antigen receptor T cell–treated mice ML Sentman, JM Murad, WJ Cook, MR Wu, J Reder, SH Baumeister, ... The Journal of Immunology 197 (12), 4674-4685, 2016 | 68 | 2016 |
| Key aspects of the immunobiology of haploidentical hematopoietic cell transplantation SHC Baumeister, B Rambaldi, RM Shapiro, R Romee Frontiers in Immunology 11, 191, 2020 | 58 | 2020 |
| Outcomes after nonresponse and relapse post-tisagenlecleucel in children, adolescents, and young adults with B-cell acute lymphoblastic leukemia LM Schultz, A Eaton, C Baggott, J Rossoff, S Prabhu, AK Keating, ... Journal of Clinical Oncology 41 (2), 354-363, 2023 | 54 | 2023 |
| Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy JM Murad, SH Baumeister, L Werner, H Daley, H Trébéden-Negre, ... Cytotherapy 20 (7), 952-963, 2018 | 54 | 2018 |
| Chimeric antigen receptor T cells targeting NKG2D-ligands show robust efficacy against acute myeloid leukemia and T-cell acute lymphoblastic leukemia L Driouk, JK Gicobi, Y Kamihara, K Rutherford, G Dranoff, J Ritz, ... Frontiers in Immunology 11, 580328, 2020 | 48 | 2020 |
| Safety data from a first-in-human phase 1 trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma S Nikiforow, L Werner, J Murad, M Jacobs, L Johnston, S Patches, ... Blood 128 (22), 4052, 2016 | 47 | 2016 |
| Increased Loss of CCR5+ CD45RA− CD4+ T Cells in CD8+ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys RS Veazey, PM Acierno, KJ McEvers, SHC Baumeister, GJ Foster, ... Journal of virology 82 (11), 5618-5630, 2008 | 47 | 2008 |
| Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys MH Newberg, KJ McEvers, DA Gorgone, MA Lifton, SHC Baumeister, ... The Journal of Immunology 176 (1), 319-328, 2006 | 45 | 2006 |
| Contribution of CD8+ T Cells to Containment of Viral Replication and Emergence of Mutations in Mamu-A*01-Restricted Epitopes in Simian Immunodeficiency … EY Kim, RS Veazey, R Zahn, KJ McEvers, SHC Baumeister, GJ Foster, ... Journal of virology 82 (11), 5631-5635, 2008 | 27 | 2008 |
| CD33 CAR T-cells (CD33CART) for children and young adults with relapsed/refractory AML: dose-escalation results from a phase I/II multicenter trial NN Shah, SK Tasian, ME Kohler, EM Hsieh, SHC Baumeister, ... Blood 142 (Supplement 1), 771-771, 2023 | 21 | 2023 |
| G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity SHC Baumeister, K Hölig, M Bornhäuser, M Meurer, EP Rieber, ... Blood, The Journal of the American Society of Hematology 110 (8), 3078-3081, 2007 | 19 | 2007 |
| Phase I trial of autologous CAR T cells targeting NKG2D ligands in patients with AML/MDS and multiple myeloma. Cancer Immunol Res. 2019; 7 (1): 100–12 SH Baumeister, J Murad, L Werner, H Daley, H Trebeden-Negre, ... CIR-18-0307.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 19 | |
| Cytokine release syndrome and associated acute toxicities in pediatric patients undergoing immune effector cell therapy or hematopoietic cell transplantation SHC Baumeister, GS Mohan, A Elhaddad, L Lehmann Frontiers in oncology 12, 841117, 2022 | 17 | 2022 |
| HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL KO McNerney, SJ Si Lim, K Ishikawa, A Dreyzin, A Vatsayan, JJ Chen, ... Blood advances 7 (12), 2758-2771, 2023 | 16 | 2023 |
| A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma S Nikiforow, J Murad, H Daley, H Negre, J Reder, CL Sentman, ... J Clin Oncol 34 (15 Suppl), TPS3102, 2016 | 16 | 2016 |
| Microsurgical lymphatic vascular grafting and secondary liposuction: Results of combination treatment in secondary lymphedema RGH Baumeister, J Wallmichrath, M Weiss, SHC Baumeister, A Frick Lymphology 53 (1), 38-47, 2020 | 8 | 2020 |
| Chimeric antigen receptor T cells targeting NKG2D-ligands show robust efficacy against acute myeloid leukemia and T-cell acute lymphoblastic leukemia L Driouk, J Gicobi, Y Kamihara, K Rutherford, G Dranoff, J Ritz, ... Blood 134, 1930, 2019 | 7 | 2019 |
| Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world … V Barsan, Y Li, S Prabhu, C Baggott, K Nguyen, H Pacenta, CL Phillips, ... EClinicalMedicine 65, 2023 | 6 | 2023 |
